QQQ   318.38 (+0.86%)
AAPL   163.16 (+0.49%)
MSFT   284.57 (+0.18%)
META   210.34 (+1.20%)
GOOGL   102.57 (+1.67%)
AMZN   103.08 (+1.06%)
TSLA   202.80 (+3.85%)
NVDA   274.64 (+0.30%)
NIO   10.51 (+0.48%)
BABA   102.17 (-1.17%)
AMD   97.09 (-0.81%)
T   19.12 (+0.21%)
F   12.49 (+1.63%)
MU   61.20 (-3.00%)
CGC   1.78 (+1.13%)
GE   95.46 (+1.50%)
DIS   99.10 (+1.02%)
AMC   5.00 (+0.60%)
PFE   40.37 (-0.02%)
PYPL   75.10 (+0.95%)
NFLX   340.94 (+0.74%)
QQQ   318.38 (+0.86%)
AAPL   163.16 (+0.49%)
MSFT   284.57 (+0.18%)
META   210.34 (+1.20%)
GOOGL   102.57 (+1.67%)
AMZN   103.08 (+1.06%)
TSLA   202.80 (+3.85%)
NVDA   274.64 (+0.30%)
NIO   10.51 (+0.48%)
BABA   102.17 (-1.17%)
AMD   97.09 (-0.81%)
T   19.12 (+0.21%)
F   12.49 (+1.63%)
MU   61.20 (-3.00%)
CGC   1.78 (+1.13%)
GE   95.46 (+1.50%)
DIS   99.10 (+1.02%)
AMC   5.00 (+0.60%)
PFE   40.37 (-0.02%)
PYPL   75.10 (+0.95%)
NFLX   340.94 (+0.74%)
QQQ   318.38 (+0.86%)
AAPL   163.16 (+0.49%)
MSFT   284.57 (+0.18%)
META   210.34 (+1.20%)
GOOGL   102.57 (+1.67%)
AMZN   103.08 (+1.06%)
TSLA   202.80 (+3.85%)
NVDA   274.64 (+0.30%)
NIO   10.51 (+0.48%)
BABA   102.17 (-1.17%)
AMD   97.09 (-0.81%)
T   19.12 (+0.21%)
F   12.49 (+1.63%)
MU   61.20 (-3.00%)
CGC   1.78 (+1.13%)
GE   95.46 (+1.50%)
DIS   99.10 (+1.02%)
AMC   5.00 (+0.60%)
PFE   40.37 (-0.02%)
PYPL   75.10 (+0.95%)
NFLX   340.94 (+0.74%)
QQQ   318.38 (+0.86%)
AAPL   163.16 (+0.49%)
MSFT   284.57 (+0.18%)
META   210.34 (+1.20%)
GOOGL   102.57 (+1.67%)
AMZN   103.08 (+1.06%)
TSLA   202.80 (+3.85%)
NVDA   274.64 (+0.30%)
NIO   10.51 (+0.48%)
BABA   102.17 (-1.17%)
AMD   97.09 (-0.81%)
T   19.12 (+0.21%)
F   12.49 (+1.63%)
MU   61.20 (-3.00%)
CGC   1.78 (+1.13%)
GE   95.46 (+1.50%)
DIS   99.10 (+1.02%)
AMC   5.00 (+0.60%)
PFE   40.37 (-0.02%)
PYPL   75.10 (+0.95%)
NFLX   340.94 (+0.74%)
NASDAQ:ARIA

Ariad Pharmaceuticals - ARIA Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range
$23.99
$23.99
50-Day Range
N/A
52-Week Range
$4.67
$23.99
Volume
N/A
Average Volume
15.70 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ARIA stock logo

About Ariad Pharmaceuticals (NASDAQ:ARIA) Stock

ARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. The Company is focused on transforming the lives of cancer patients with medicines. The Company's product pipeline includes Iclusig (ponatinib), brigatinib, AP32788 and ridaforolimus. The Company's Iclusig is a tyrosine kinase inhibitor (TKI) that is approved in the United States, the European Union, Australia, Switzerland, Israel and Canada for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Its Brigatinib is an investigational inhibitor of anaplastic lymphoma kinase (ALK). Its AP32788 is a TKI, which is designed as a targeted therapy for patients with non-small cell lung cancer (NSCLC) with specific mutations in two kinases, epidermal growth factor receptor (EGFR), or human epidermal growth factor receptor 2 (HER2). Its Ridaforolimus is an investigational inhibitor of the mammalian target of rapamycin (mTOR).

Receive ARIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ariad Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARIA Stock News Headlines

Anti-Cancer Drug Market Size and Forecast till 2031
Biden's corruption knows no end
Porter Stansberry here -- I reveal the shocking changes this Obama policy will usher in… what it means for you, your family, and your finances… and how you can prepare for this new American era. Stream my new documentary at no cost today.pixel
Iclusig Market Top Players and Forecast till 2031
Biden's corruption knows no end
Porter Stansberry here -- I reveal the shocking changes this Obama policy will usher in… what it means for you, your family, and your finances… and how you can prepare for this new American era. Stream my new documentary at no cost today.pixel
See More Headlines
Receive ARIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ariad Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARIA Company Calendar

Last Earnings
7/28/2016
Today
3/31/2023

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
Biotechnology
Sector
N/A
Current Symbol
NASDAQ:ARIA
CUSIP
04033A10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A














ARIA Stock - Frequently Asked Questions

How were Ariad Pharmaceuticals' earnings last quarter?

Ariad Pharmaceuticals Inc (NASDAQ:ARIA) released its quarterly earnings data on Thursday, July, 28th. The pharmaceutical company reported $0.59 EPS for the quarter, beating the consensus estimate of ($0.11) by $0.70. The pharmaceutical company had revenue of $65.30 million for the quarter, compared to analysts' expectations of $60.64 million. Ariad Pharmaceuticals's revenue for the quarter was up 133.0% compared to the same quarter last year. During the same period last year, the company earned ($0.28) earnings per share.

What other stocks do shareholders of Ariad Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ariad Pharmaceuticals investors own include Synergy Pharmaceuticals (SGYP), Twitter (TWTR), Exelixis (EXEL), Gilead Sciences (GILD), ACADIA Pharmaceuticals (ACAD), Achillion Pharmaceuticals (ACHN), Array Technologies (ARRY), Alphabet (GOOG), Netflix (NFLX) and Ford Motor (F).

What is Ariad Pharmaceuticals' stock symbol?

Ariad Pharmaceuticals trades on the NASDAQ under the ticker symbol "ARIA."

What is Ariad Pharmaceuticals' stock price today?

One share of ARIA stock can currently be purchased for approximately $23.99.

How can I contact Ariad Pharmaceuticals?

Ariad Pharmaceuticals' mailing address is 125 Binney St, CAMBRIDGE, MA 02142-1123, United States. The official website for the company is www.ariad.com. The pharmaceutical company can be reached via phone at +1-617-4940400.

This page (NASDAQ:ARIA) was last updated on 3/31/2023 by MarketBeat.com Staff